Skip to main content
. 2026 Mar 14;19(3):477. doi: 10.3390/ph19030477
AEFI Adverse Event Following Immunization
AESI Adverse Event of Special Interest
CI Confidence Interval
GBS Guillain–Barré syndrome
ICU Intensive care unit
IQR Interquartile range
NVV Non-virus-vectored (adenoviral vector–based) COVID-19 vaccines
PAC-VR Pharmacovigilance Autonomic Center of the Valencia Region
PCR Polymerase Chain Reaction
RR Relative Risk
VID Integrated Database of the Valencian Health System
VIS Vaccine Information System